Digostics, a UK-based diabetes home-testing provider, who graduated from our NHS Market Access Accelerator programme in 2022 have partnered with Medway NHS Foundation Trust to transform local gestational diabetes screening, by offering world-first home oral glucose tolerance testing (OGTT) technology to all at-risk women.
The MHRA published the findings of the National Commission into the Regulation of AI in Healthcare's Call for Evidence, the most substantial assessment yet of how the UK should regulate AI in health and care. The Commission is the independent advisory group…
Hospices across England are being offered access to a new NHS-backed AI programme designed to give doctors and nurses more time with patients during the final stages of life.
The initiative will provide selected hospices with free access to CLEARnotes,…
Attendees
Sponsors and Exhibitors
Contact us